Teva Pharmaceuticals
TEVA
TEVA
556 hedge funds and large institutions have $13.7B invested in Teva Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 172 increasing their positions, 170 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
556
Holders Change
+17
Holders Change %
+3.15%
% of All Funds
12.73%
Holding in Top 10
14
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-12.5%
% of All Funds
0.32%
New
79
Increased
172
Reduced
170
Closed
59
Calls
$596M
Puts
$625M
Net Calls
-$29M
Net Calls Change
+$122M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$183M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$104M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$84.5M |
| 4 |
BMO
Beck Mack & Oliver
New York
|
+$64.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$49.4M |
Top Sellers
| 1 |
NC
Northern Cross
Boston,
Massachusetts
|
-$466M |
| 2 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$281M |
| 3 |
PC
PointState Capital
New York
|
-$162M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$123M |
| 5 |
Millennium Management
New York
|
-$105M |
